Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
Start Today
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //
Log in
Globe Shop

Reader services

  • Subscriptions
  • Settings
  • Customer Help
  • Log in
  • Log out

Getting audio file ...

Audio for this article is not available at this time.

This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer

Give Justin Trudeau credit for one thing: The man knows how to deflect. As news broke in recent weeks of the first vaccines against the coronavirus to pass phase 3 clinical trials, from Pfizer, Moderna and AstraZeneca, and as it emerged the vaccines would begin distribution in some countries as early as next month, the Prime Minister could see the question coming: When will they be available in Canada?

The answer, we now know, is later: much later. Possibly months later. But as that might reflect poorly on the Prime Minister and the government he leads, he changed the subject.

“One of the things to remember is Canada no longer has any domestic production capacity for vaccines,” Mr. Trudeau admonished members of the media at his Tuesday news conference. “We used to have it decades ago, but we no longer have it. Countries like the United States, Germany and the U.K. do have domestic pharmaceutical facilities, which is why they’re obviously going to prioritize helping their citizens first.”

Story continues below advertisement

Maclean’s in August, University of Ottawa epidemiologist and law professor Amir Attaran offered one explanation: “Because the Trudeau government dithered. When our closest allies put their money down and placed orders for over a billion vaccine doses, our government failed to keep up.”

Perhaps that is why the government eventually purchased so many doses, among the largest, per capita, in the world – to make up in volume what it lost in timeliness. According to the Toronto Star, the way was open for it to pay a premium “to be near the front of the line,” and in some cases, the government took it. Could it have tried harder, acted sooner, bid higher? Or was the government, as Prof. Attaran suggests, blinded by “incompetent nationalism,” consumed with supporting long-shot local initiatives that failed to pan out, only to find it was too late to get first crack at the good stuff?

At any rate, hold on – it can only get worse. Even assuming Health Canada parts with the habits of a lifetime and approves the first vaccine more or less simultaneously with its U.S. and European counterparts, and even assuming the vaccines can be shipped to Canada in advance of approval, and stored (in super-cold conditions) until then, that still leaves the ultimate logistical nightmare: getting them into the arms of millions of Canadians, safely and speedily.

The track records of governments in this country, federal and provincial, do not fill one with optimism on this score. Even now, they are wrangling over how the vaccines should be allocated among provinces: whether it should be based on the number of people in each, or the number of cases, or the number of the elderly, or some other basis.

Quite what the people who, in eight months of trying, still can’t test more than about 50,000 people a day for the disease, will make of the challenge of vaccinating the entire population, one shudders to think. But if they’re even halfway done this time next year, it will be a pleasant surprise.

Canadian ities are assessing COVID-19 vaccine candidates while trials are underway, speeding up any eventual approval for wide use. But science reporter Ivan Semeniuk says it’s likely high-risk people will be prioritized for receiving any vaccine first, with some possibly getting it as early as the first part of 2021. The Globe and Mail

Sign up for theRead more about following topics and s

Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Facebook and Twitter .

Log in Subscribe to comment Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Facebook and Twitter .

I'm a print subscriber, link to my account Subscribe to comment Why do I need to subscribe?

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately it is being reviewed by our moderation team and may appear shortly.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

Read our community guidelines here

Discussion loading ...

Read most recent letters to the editor.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies